Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the body’s nerves. Immune cells ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support ...

Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on ...

Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...

Ibex's high-performance AI platform--already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche--now supports ...

In recent developments, Roche has featured prominently in the race to develop TIGIT inhibitors for cancer immunotherapy, while Ibex Medical Analytics expanded its AI pathology platform to support ...

Hera Women's Health is highlighting results from the PRIME multicenter randomized controlled trial sponsored by Sera Prognostics, Inc., with Brian K. Iriye, MD (Hera Women's Health) serving as the ...

Researchers at UC San Francisco have devised a method to identify pneumonia — using both genetic information and AI — that ...

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...